Chardan downgraded Cargo Therapeutics (CRGX) to Neutral from Buy without a price target The company will be discontinuing the Phase II FIRCE-1 ...

Fintel reports that on January 30, 2025, Chardan Capital downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from ...

CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by stock analysts at Chardan Capital from a “buy” rating to ...

Chardan analyst Geulah Livshits downgraded Editas Medicine (EDIT) to Neutral from Buy and withdrew the firm’s price target after the company announced a strategic transition to focus entirely on ...

Fintel reports that on December 11, 2024, Chardan Capital downgraded their outlook for CervoMed (NasdaqCM:CRVO) from Buy to Neutral. Analyst Price Forecast Suggests 2,434.26% Upside As of December ...

Chardan Capital Markets has recently initiated Mind Medicine (MindMed) Inc (MNMD) stock to Buy rating, as announced on December 20, 2024, according to Finviz. Earlier, on October 14, 2024, Leerink ...

Xilio Therapeutics Inc (XLO) stock saw a decline, ending the day at $0.89 which represents a decrease of $-0.38 or -29.92% from the prior close of $1.27. The stock opened at $0.96 and touched a low of ...

CARGO Therapeutics, Inc. (CRGX – Research Report) received a Hold rating and price target from Chardan Capital analyst Geulah Livshits ...